Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Yes, a 2026 meta-analysis found that early-day immune checkpoint inhibitor administration improves overall survival in advanced solid tumors, including non-small cell lung cancer.
Yes, Lazcluze (lazertinib) is FDA-approved for first-line treatment of locally advanced or metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858R mutations, in combination…
Scientists are improving flu vaccines by combining them with other vaccines, using intranasal delivery, and engineering virus-like particles to trigger broader immune responses.
Yes, pembrolizumab alone is a standard first-line treatment for advanced NSCLC with PD-L1 ≥50%, with real-world data showing mean overall survival of 21 months and 29% survival…
Yes, coadministering the high-dose flu shot and RSV vaccine is safe and works well for seniors, though the RSV immune response may be slightly lower.
Lab findings often don't translate to real-world HCC care due to tumor heterogeneity, racial disparities, and lack of validated biomarkers for routine use.
Yes, text-message CBT (CBT-txt) significantly reduces depressive symptoms in young adults with major depressive disorder, based on multiple randomized trials.
Yes, advanced liver fibrosis (stage F3-F4) significantly increases the risk of developing hepatocellular carcinoma compared to no or mild fibrosis, with higher cumulative…
Yes, Auvelity (dextromethorphan/bupropion) is FDA-approved for treating major depressive disorder in adults.
No, JNJ-42165279 did not improve depression in a clinical trial of people whose SSRI/SNRI was not working well enough.
Microvascular decompression for trigeminal neuralgia in multiple sclerosis patients has a long-term pain-free success rate of about 30.2%, based on a 2024 systematic review.
Inpatient rehabilitation for MS includes gait training, robot-assisted therapy, strength, balance, and aerobic exercises, all showing mobility and fatigue benefits.
The incidence of Multiple Sclerosis in women of childbearing age has increased by 48% from 1990 to 2021, according to a global burden of disease study.
Yes, advanced liver scarring (fibrosis/cirrhosis) significantly raises your risk of developing hepatocellular carcinoma, especially in MASLD patients.
Yes, both aerobic and strength training can reduce fatigue in people with multiple sclerosis, with studies showing similar benefits from each modality.
Yes, Black patients have worse survival after liver transplant for hepatocellular carcinoma, with a 27% higher risk of death compared to White patients.
CAR-T cell therapies are not yet approved for MS but are being tested in clinical trials, with early results showing safety and potential benefit.
Yes, potassium salt substitutes lower blood pressure and reduce cardiovascular death risk, based on multiple reviews and trials.
Micro-ultrasound and mpMRI detect clinically significant prostate cancer at similar rates, so neither is clearly better; your choice depends on availability and your doctor's…
Risk calculators like Heart Age, along with LDL-C and blood pressure numbers, help patients with CVD understand their personal risk. Tools that show 'heart age' can motivate risk…
AI models analyze your biopsy images, genetic data, and PSA levels to predict cancer outcomes like survival and recurrence, helping guide treatment decisions.
Chronic air pollution worsens heart conditions in children and older adults by triggering inflammation, oxidative stress, and vascular damage, with older adults facing higher…
Yes, bibliometric data and recent studies confirm that research interest in macrophage polarization strategies for prostate cancer has been growing steadily since 2015.
Extracellular vesicles (EVs) can both promote and inhibit vascular calcification in cardiovascular disease, depending on their cargo and cellular origin.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.